Evidence map›Paper›PMID 27711191›Full record

ArticlePLoS pathogens2016

Vasodilator-Stimulated Phosphoprotein Activity Is Required for Coxiella burnetii Growth in Human Macrophages.

Punsiri M Colonne, Caylin G Winchell, Joseph G Graham, Frances I Onyilagha, Laura J MacDonald, Heike R Doeppler, Peter Storz, Richard C Kurten, Paul A Beare, Robert A Heinzen and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Establishing the intracellular niche of obligate intracellular vacuolar pathogens.Frontiers in cellular and infection microbiology · 2023
    Review
  3. Article
  4. Article
  5. TheFrontiers in cellular and infection microbiology · 2020
    Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Punsiri M ColonneDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.
Caylin G WinchellDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.
Joseph G GrahamDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.
Frances I OnyilaghaDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.
Laura J MacDonaldDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.
Heike R DoepplerDepartment of Cancer Biology, Mayo Clinic, Jacksonville, Florida, United States of America.
Peter StorzDepartment of Cancer Biology, Mayo Clinic, Jacksonville, Florida, United States of America.
Richard C KurtenDepartment of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.
Paul A BeareCoxiella Pathogenesis Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
Robert A HeinzenCoxiella Pathogenesis Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.ORCID http://orcid.org/0000-0001-6870-4619
Daniel E VothDepartment of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.
University of Arkansas for Medical Sciences · USMayo Clinic in Florida · USNational Institutes of Health · USArkansas Children's Hospital · US

Funding

Zosuquidar trihydrochloride for acute myeloid leukemia &refractory anemiaM01RR000080 · NCRR · UNIVERSITY HOSPITALS OF CLEVELAND · PI DAVIS, PAMELA B · 1985 to 2007
$22.2M
Study of the Cell-specific Inflammasome Responses During Defense Against Gram-negative BacteriaP20GM103625 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI SMELTZER, MARK S · 2012 to 2021
$21.5M
Cellular and Developmental Biology of Coxiella burnetiiZIAAI000931 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI HEINZEN, ROBERT A · 2009 to 2023
$11.8M
Arkansas Center for Clinical and Translational ResearchUL1TR000039 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI BECK, CORNELIA MARIE, JAMES, LAURA P · 2012 to 2014
$10.0M
The University of Arkansas for Medical Sciences Initiative for Maximizing Student Development ProgramR25GM083247 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI MCGEHEE, ROBERT E, THOMAS, BILLY R · 2009 to 2023
$5.4M
Role of the Coxiella burnetii Cryptic Plasmid in Host Cell ParasitismR01AI087669 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI VOTH, DANIEL E · 2010 to 2014
$1.9M
Role of Protein Kinase D in Actin Remodeling and Cell MotiliyR01GM086435 · NIGMS · MAYO CLINIC JACKSONVILLE · PI STORZ, PETER · 2010 to 2013
$1.1M
Coxiella burnetii Regulation of Macrophage cAMP/PKA SignalingR21AI107148 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI VOTH, DANIEL E · 2013 to 2014
$379k
NCATS NIH HHS UL1 TR000039NCRR NIH HHS M01 RR000080NIAID NIH HHS R01 AI087669NIAID NIH HHS R21 AI107148NIGMS NIH HHS P20 GM103625NIGMS NIH HHS R01 GM086435NIGMS NIH HHS R25 GM083247
6 · The paper itself

Abstract

Coxiella burnetii is an intracellular bacterial pathogen that causes human Q fever, an acute flu-like illness that can progress to chronic endocarditis and liver and bone infections. Humans are typically infected by aerosol-mediated transmission, and C. burnetii initially targets alveolar macrophages wherein the pathogen replicates in a phagolysosome-like niche known as the parasitophorous vacuole (PV). C. burnetii manipulates host cAMP-dependent protein kinase (PKA) signaling to promote PV formation, cell survival, and bacterial replication. In this study, we identified the actin regulatory protein vasodilator-stimulated phosphoprotein (VASP) as a PKA substrate that is increasingly phosphorylated at S157 and S239 during C. burnetii infection. Avirulent and virulent C. burnetii triggered increased levels of phosphorylated VASP in macrophage-like THP-1 cells and primary human alveolar macrophages, and this event required the Cα subunit of PKA. VASP phosphorylation also required bacterial protein synthesis and secretion of effector proteins via a type IV secretion system, indicating the pathogen actively triggers prolonged VASP phosphorylation. Optimal PV formation and intracellular bacterial replication required VASP activity, as siRNA-mediated depletion of VASP reduced PV size and bacterial growth. Interestingly, ectopic expression of a phospho-mimetic VASP (S239E) mutant protein prevented optimal PV formation, whereas VASP (S157E) mutant expression had no effect. VASP (S239E) expression also prevented trafficking of bead-containing phagosomes to the PV, indicating proper VASP activity is critical for heterotypic fusion events that control PV expansion in macrophages. Finally, expression of dominant negative VASP (S157A) in C. burnetii-infected cells impaired PV formation, confirming importance of the protein for proper infection. This study provides the first evidence of VASP manipulation by an intravacuolar bacterial pathogen via activation of PKA in human macrophages.

Indexed as

Cell Adhesion MoleculesCoxiella burnetiiCyclic AMP-Dependent Protein KinasesEnzyme ActivationGene Knockdown TechniquesHost-Pathogen InteractionsHumansImmunoblottingImmunoprecipitationMacrophages, AlveolarMicrofilament ProteinsMicroscopy, ConfocalPhosphoproteinsQ FeverVasodilator-Stimulated PhosphoproteinCell Adhesion MoleculesCyclic AMP-Dependent Protein KinasesMicrofilament ProteinsPhosphoproteinsVasodilator-Stimulated Phosphoprotein

Identifiers

PMID27711191
PMCPMC5053435
OpenAlexW2528216864

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.